Cleared Special

K001592 - ECHOCOM

K001592 is an FDA 510(k) clearance for ECHOCOM, manufactured by Tomtec Imaging Systems GmbH. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2000
Decision
24d
Days
Class 2
Risk

K001592 is an FDA 510(k) clearance for the ECHOCOM, IMAGECOM, DOKUCOM. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Tomtec Imaging Systems GmbH (Unterschleissheim, DE). The FDA issued a Cleared decision on June 16, 2000 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Tomtec Imaging Systems GmbH devices

FDA 510(k) Submission Details - K001592

510(k) Number K001592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2000
Decision Date June 16, 2000
Days to Decision 24 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 125d · This submission: 24d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 271
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K001592.
ASTRONOMER+WITH SLD
K003362 · Boston Scientific Corp · Mar 2001
CATHCOR DESKTOP
K002137 · Siemens Elema AB · Oct 2000
MAC-LAB SYSTEM AND CARDIOLAB EP SYSTEM
K001305 · General Electric Medical Systems Information Techn · Jun 2000
MODIFICATION TO CARTO EP NAVIGATION SYSTEM
K000190 · Biosense Webster, Inc. · May 2000
CARTO EP NAVIGATION SYSTEM
K000248 · Biosense Webster, Inc. · May 2000
NOGA CARDIAC NAVIGATION SYSTEM
K000332 · Biosense Webster, Inc. · May 2000